I know but if it works with one ( the way it worked ), why shouldn't it work for many others? But of course, it can't be approved after one patient.
But HIV....no doubt....so what could prevent us from FDA approval? Experts, please.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-